Point-of-Care/Rapid Diagnostics Market

Point-of-Care/Rapid Diagnostics Market by Testing (Glucose, Lipids, HbA1c, HCV, HIV, Influenza, Urinalysis, Hematology, Cancer, Pregnancy, PT/INR), Platform (Lateral Flow, Immunoassay), Mode (Prescription, OTC), End-User - Global Forecast to 2022

Report Code: MD 2702 Feb, 2018, by marketsandmarkets.com

[226 Pages Report] The global Point-of-Care Diagnostics market was valued at USD 21.40 Billion in 2016 and is expected to reach USD 38.13 Billion by 2022, at a CAGR of 10.0% during the forecast period.

  • Base Year: 2016
  • Forecast Period: 2017–2022

Objectives of the study are:

  • To define, describe, and forecast the global Point-of-Care Diagnostics market by product, prescription mode, end user, platform, and region
  • To provide detailed information regarding the major factors influencing the growth of the Rapid Diagnostics Market (drivers, restraints, opportunities, and industry-specific challenges)
  • To strategically analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the total Rapid Diagnostics Market
  • To analyze the opportunities in the Rapid Diagnostics Market for stakeholders and provide details of the competitive landscape for market leaders
  • To provide a five-year forecast for various segments of the global market in terms of revenue with respect to the four main regions, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW)
  • To strategically profile the key players and comprehensively analyze their Rapid Diagnostics Market shares and core competencies
  • To track and analyze competitive developments such as product launches; agreements, partnerships, collaborations, and joint ventures; and mergers and acquisitions in the global rapid diagnostics market

This research study involved the extensive usage of secondary sources, directories, and databases (such as D&B and Factiva), to identify and collect information useful for this technical, market-oriented, and financial study of the Point-of-Care Diagnostics market. In-depth interviews were conducted with various primary respondents, including subject-matter experts (SMEs), C-level executives of key market players, and industry consultants to obtain and verify qualitative and quantitative information and to assess market prospects.

Point-Of-Care Diagnostics Market

To know about the assumptions considered for the study, download the pdf brochure

As of 2016, the point-of-care diagnostics market was dominated by Roche (Switzerland), Abbott (US), and Siemens (Germany) respectively. Other players in this Rapid Diagnostics Market include Instrumentation Laboratory (US), Nova (US), PTS Diagnostics (US), Sekisui Diagnostics (US), Quidel (US), EKF Diagnostics (UK), Chembio Diagnostics (US), Trinity Biotech (US), and AccuBioTech (China), among others.

Stakeholders

  • Point-of-care diagnostics manufacturing companies
  • Point-of-care diagnostics distribution companies
  • Clinical laboratories
  • Hospitals, clinics, and special areas (such as sports and military)
  • Research institutes and clinical research organizations (CROs)
  • Market research and consulting firms

Scope of the Report

This report categorizes the global rapid diagnostics market into the following segments and subsegments:

Global Point-of-Care Diagnostics Market, by Product

  • Glucose Monitoring Products
  • Cardiometabolic Testing Products
  • Infectious Disease Testing Products
  • Coagulation Testing Products
  • Pregnancy & Fertility Testing Products
  • Tumor/Cancer Marker Testing Products
  • Urinalysis Testing Products
  • Cholesterol Testing Products
  • Hematology Testing Products
  • Drugs-of-Abuse Testing Products
  • Fecal Occult Testing Products
  • Other POC Products

Global Point-of-Care Diagnostics Market, by Platform

  • Lateral Flow Assays
  • Dipsticks
  • Microfluidics
  • Molecular Diagnostics
  • Immunoassays

Global Point-of-Care Diagnostics Market, by Mode 

  • Prescription-based Testing
  • OTC-based Testing

Global Point-of-Care Diagnostics Market, by End User

  • Professional Diagnostic Centers
  • Research Laboratories
  • Home Care
  • Other End Users

Global Point-of-Care Diagnostics Market, by Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Rest of Europe (RoE)
  • Asia Pacific
    • Japan
    • China
    • India
    • Rest of Asia Pacific (RoAPAC)
  • Rest of the World (RoW)
    • Latin America
    • Middle East & Africa

Available Customizations

With the given Rapid Diagnostics Market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the point-of-care diagnostics market report:

Product Analysis

  • Product matrix, which gives a detailed comparison of the product portfolios of the top five companies in the rapid diagnostics market

Company Information

  • Detailed analysis and profiling of additional market players (up to 5)

Growing government support for development and adoption of POC devices and technological advancements offered by novel POC devices to drive the global point-of-care diagnostics demand close to USD 38.13 billion by 2022

Point-of-care (POCT) is an essential rapid diagnostic test used for detection of analytes near to patient, which offer better diagnosis, monitoring, and disease management. POC testing is an efficient and faster diagnostic tool, which can help offer medical diagnosis to communities without access to major healthcare facilities.

The global point-of-care diagnostics market size is projected to reach USD 38.13 Billion by 2022, largely due to increasing private investments and venture funding towards the development of new products along with the growing government support to increase the adoption of POC devices. Ongoing new product developments by leading companies for new applications of POC testing are likely to propel further growth of the market in long-term forecast.

Point-Of-Care Diagnostics Market

Stringent and time consuming regulatory policies and lack of alignment with definitive central lab methods are the major restraints for the market

For the approval of any new POC device in the US, manufacturers are required to submit performance data to the FDA. This performance data should demonstrate that healthcare professionals and patients are capable of using these devices and can obtain results similar to clinical laboratory tests. Considering all these requirements, manufacturers need to obtain multiple separate FDA clearances for launching their product into the prescription home-use market. Also, POC tests intended for point-of-laboratory (POL) testing also require special recognition from the FDA with additional site-performance data. Thus, the entire process of approval is time consuming which is one of the major factors restraining market growth.

Development of POC tests with multiplexing capabilities and increasing partnerships and acquisitions between market players, are key factors driving market demand

To meet the increasing demand for POC diagnostics across the globe, specifically in emerging markets, manufacturers are focusing on strategic acquisitions and agreements/partnerships with regional/domestic players for product distribution and manufacturing.

Further, market players are also focusing on developing POC devices, which can run multiple analytes on a single device. These multiplexing devices measure several analytes simultaneously on the same cartridge. Thus, increasing research on multiplexing technology will offer growth opportunities for this market in the coming years.

Market Dynamics

Market Drivers

  • High Prevalence of Infectious Diseases in Developing Countries
  • Increasing Incidence of Target Diseases (such as  diabetes, hematology disorders, cancer, and cardiac disorders)
  • Rising Usage of Home-Based POC Devices
  • Growing Government Support for development and adoption of POC devices
  • Technological Advancements and New Product Launches
  • Growing Number of Regulatory Approvals for Novel Immunoassay Techniques
  • Shortage of Skilled Laboratory Technicians
  • Rising Number of CLIA-Waived POC Tests

Market Restraints

  • Product Recalls: Hampering User Confidence
  • Pricing Pressure Owing to Reimbursement Cuts and Budget Constraints
  • Stringent and Time-Consuming Regulatory Policies are Significantly Increasing Gestation Period for Product Launches

Market Opportunities

  • Growth Opportunities in Emerging Markets
  • Healthcare Decentralization Converting Lab Tests to POC Tests
  • Increasing Number of Conferences and Events
  • POC Tests with Multiplexing Capabilities

Market Challenges

  • Lack of Alignment with Definitive Central Lab Methods
  • Inadequate Knowledge about the Use of POC Devices in Professional Settings
  • Reluctance towards Changing Existing Diagnostic Practices
  • High Cost of Devices

Leading point-of-care diagnostic manufacturers are developing innovative solutions for existing and new applications of POC to drive the market forward

Number of prospective POC diagnostic devices have been developed during recent years, which are paving way for emerging applications in this market. In line with this, technologies such as microfluidics, lab-on-a-chip technology, lateral flow assays, wearables, breath tests, non-invasive technologies, and biosensors are used for developing advanced POC devices.

Point-Of-Care Diagnostics Market

Sepsis biomarkers

With the aim to improve the management of sepsis for early identification and administration of antimicrobial therapy, researchers are focusing on developing novel point-of-care testing devices for the management of sepsis. Rapid POC testing for sepsis diagnosis provides several advantages as compared to blood culture for identification. In line with this, Radiometer Medical ApS (Denmark) launched a novel POC test for diagnosis of sepsis. Likewise, researchers from the University of Illinois (US) also developed a POC microfluidic chip for detection of sepsis.

Stroke Markers

Stroke is a time-dependent medical emergency, which requires early presentation to specialists with the aim to reduce deaths. Recent innovations, such as the use of POCT in ambulances, have paved the way to new perspectives in the management of patients before they reach hospital. The use of POCT also helps in reducing risks of stroke mimics or contraindications for thrombolysis treatment administration.

Thyroid Testing

Thyroid testing helps in analysing the proper functioning of the thyroid gland for detecting problems such as hyperthyroidism or hypothyroidism. The thyroid hormone plays a crucial role in normal growth and development of the body and brain, especially in newborns and infants. In most cases, thyroid disease is treated on an outpatient basis, which requires rapid and cost-effective assays. Thus, companies are developing point-of-care products to enable the prompt diagnosis and treatment of thyroid disorders.

There is a long list of such new product developments and unique formulations for a range of other applications such as DNA testing, Endocrine testing, and antimicrobial resistance testing, among others.

Key Questions

  • How reimbursement cuts across various geographies will impact POC testing moving forward?
  • Introduction of low cost products in the market is impacting the market for big players due to cost difference among products. How will pricing difference impact the overall market?
  • Emerging markets have been witnessing recent trend of population based wellness screening for diabetes and heart disease. Who are the major organizations driving this trend (NGOs, WHO, Govt)? What are the biggest opportunities for these organizations?
  • Most of the data available for rapid testing which is from lab or IVD driven and physician office is highly variable and unreliable. What approach can be used to gather reliable data on rapid testing business globally?
  • What will be termed as an accurate market segmentation down to true point of care settings?
  • The trend for cardiac testing and blood gas testing is increasing globally. How many point of care locations do this testing globally and how does this break out by location. In addition who are the payers for this testing procedures (government, private, employer, community, self-pay) by region/country?

The global Point-of-Care Diagnostics market is projected to reach USD 38.13 Billion by 2022 from USD 23.71 Billion in 2017, at a CAGR of 10.0% during the forecast period. Factors such as high prevalence of infectious diseases in developing countries, increasing incidence of target diseases, and rising preference for home healthcare across the globe are increasing the adoption of POC diagnostics products globally.

This report broadly segments the rapid diagnostics market into product, platform, mode, end user, and region.

On the basis of product, the global Point-of-Care Diagnostics market is segmented into products for glucose monitoring, infectious disease testing, coagulation testing, cardiometabolic testing, hematology testing, urinalysis testing, cholesterol testing, drugs of abuse testing, tumor/cancer marker testing, pregnancy and fertility testing, fecal occult testing, and others (multi-assay testing, liver testing, hepatitis A & B testing, and vitamin assay testing). The infectious disease testing products segment is expected to grow at the highest CAGR during the forecast period. The growing patient population base and increasing availability and awareness about infectious disease POC testing products are the major factors contributing to the segment’s growth.

Based on platforms, the Point-of-Care Diagnostics market is further segmented into lateral flow assays, immunoassays, POC molecular diagnostics, dipsticks, and microfluidics. The molecular diagnostics segment is expected to grow at the highest CAGR during the forecast period. The growth of this segment can be attributed to the growing advancements in technology, increasing initiatives of market players for developing POC molecular diagnostics products, and resource-limited settings.

On the basis of mode of prescription, the Point-of-Care Diagnostics market is categorized into two segments prescription-based testing and OTC testing. The prescription-based testing segment is expected to command the largest share of the global point-of-care diagnostics market in 2017. The growth of this segment can be attributed to the increasing incidence and prevalence of lifestyle diseases and the lack of awareness on OTC POCT devices in developing nations.

On the basis of end user, the Point-of-Care Diagnostics market is further segmented into professional diagnostics centers, home care, research laboratories, and other end users. The home care settings segment is expected to grow at the highest CAGR during the forecast period. The high growth of this segment can be attributed to the increasing preference for home and remote monitoring and rising demand for rapid tests among home care users.

Point-Of-Care Diagnostics Market

The report covers the Point-of-Care Diagnostics market across four major geographies, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America is expected to command the largest share of the Rapid Diagnostics Market in 2017, due to the growing prevalence of lifestyle diseases, increasing number of product approvals, and rising government initiatives in this region.

The major players of the Point-of-Care Diagnostics market are Abbott (US), Roche (Switzerland), Siemens (Germany), Danaher (US), Becton, Dickinson, and Company (US), Johnson & Johnson (US), Instrumentation Laboratory (US), PTS Diagnostics (US), Quidel (US), Chembio (US), Sekisui Diagnostics (US), Nova (US), EKF Diagnostics (UK), AccuBioTech (China), and Trinity Biotech (US).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 18)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
    1.4 Markets Covered
           1.4.1 Years Considered for the Study
    1.5 Currency
    1.6 Limitations
    1.7 Stakeholders

2 Research Methodology (Page No. - 21)
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Primary Sources
                    2.1.2.2 Key Industry Insights
           2.1.3 Market Size Estimation Methodology
                    2.1.3.1 Bottom-Up Approach
                    2.1.3.2 Top-Down Approach
           2.1.4 Research Design
           2.1.5 Market Data Validation and Triangulation
           2.1.6 Assumptions for the Study

3 Executive Summary (Page No. - 31)
    3.1 Introduction

4 Premium Insights (Page No. - 35)
    4.1 POC Diagnostics: Market Overview
    4.2 POC Diagnostics Market, By Platform
    4.3 Geographic Analysis: POC Diagnostics Market, By End User and Region
    4.4 POC Diagnostics Market, By Product
    4.5 POC Diagnostics Market, By Prescription Mode
    4.6 Geographic Snapshot of the POC Diagnostics Market

5 Market Overview (Page No. - 40)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 High Prevalence of Infectious Diseases in Developing Countries
                    5.2.1.2 Increasing Incidence of Target Diseases
                    5.2.1.3 Rising Usage of Home-Based POC Devices
                    5.2.1.4 Growing Government Support
                    5.2.1.5 Technological Advancements and New Product Launches
                    5.2.1.6 Growing Number of Regulatory Approvals for Novel Immunoassay Techniques
                    5.2.1.7 Shortage of Skilled Laboratory Technicians
                    5.2.1.8 Rising Number of Clia-Waived POC Tests
           5.2.2 Restraints
                    5.2.2.1 Product Recalls: Hampering User Confidence
                    5.2.2.2 Pricing Pressure Owing to Reimbursement Cuts and Budget Constraints
                    5.2.2.3 Stringent and Time-Consuming Regulatory Policies are Significantly Increasing Gestation Period for Product Launches
           5.2.3 Opportunities
                    5.2.3.1 Growth Opportunities in Emerging Markets
                    5.2.3.2 Healthcare Decentralization —Converting Lab Tests to POC Tests
                    5.2.3.3 Increasing Number of Conferences and Events
                    5.2.3.4 POC Tests With Multiplexing Capabilities
           5.2.4 Challenges
                    5.2.4.1 Lack of Alignment With Definitive Central Lab Methods
                               5.2.4.1.1 Disadvantages of POC Testing Over Central Lab Methods
                    5.2.4.2 Inadequate Knowledge About the Use of POC Devices in Professional Settings
                    5.2.4.3 Reluctance Towards Changing Existing Diagnostic Practices
                    5.2.4.4 High Cost of Devices
           5.2.5 Emerging Applications of Point-of-Care Testing
                    5.2.5.1 Sepsis Biomarkers
                    5.2.5.2 Stroke Markers
                    5.2.5.3 Thyroid Testing
                    5.2.5.4 Dna Testing
                    5.2.5.5 Endocrine Testing

6 Point-of-Care Diagnostics Market, By Product (Page No. - 56)
    6.1 Introduction
    6.2 Glucose Monitoring Products
           6.2.1 Strips
           6.2.2 Meters
           6.2.3 Lancets & Lancing Devices
    6.3 Cardiometabolic Testing Products
           6.3.1 Cardiac Marker Testing Products
           6.3.2 Blood Gas/Electrolytes Testing Products
           6.3.3 HBA1C Testing Products
    6.4 Infectious Disease Testing Products
           6.4.1 Influenza Testing Products
           6.4.2 HIV Testing Products
           6.4.3 Hepatitis C Testing Products
           6.4.4 Sexually Transmitted Disease (STD) Testing Products
           6.4.5 Healthcare-Associated Infection (HAI) Testing Products
           6.4.6 Respiratory Infection Testing Products
           6.4.7 Tropical Disease Testing Products
           6.4.8 Other Infectious Disease Testing Products
    6.5 Coagulation Testing Products
           6.5.1 PT/INR Testing Products
           6.5.2 Activated Clotting Time (ACT/APTT) Testing Products
    6.6 Pregnancy and Fertility Testing Products
           6.6.1 Pregnancy Testing Products
           6.6.2 Fertility Testing Products
    6.7 Tumor/Cancer Marker Testing Products
    6.8 Urinalysis Testing Products
    6.9 Cholesterol Testing Products
    6.10 Hematology Testing Products
    6.11 Drugs-of-Abuse Testing Products
    6.12 Fecal Occult Testing Products
    6.13 Other POC Products

7 Point-of-Care Diagnostics Market, By Platform (Page No. - 94)
    7.1 Introduction
    7.2 Lateral Flow Assays (Immunochromatography Tests)
    7.3 Dipsticks
    7.4 Microfluidics
    7.5 Molecular Diagnostics
    7.6 Immunoassays

8 Point-of-Care Diagnostics Market, By Prescription Mode (Page No. - 102)
    8.1 Introduction
    8.2 Prescription-Based Testing
    8.3 OTC Testing

9 Point-of-Care Diagnostics Market, By End User (Page No. - 107)
    9.1 Introduction
    9.2 Professional Diagnostic Centers
           9.2.1 Clinical Laboratories, Outpatient Healthcare & Ambulatory Care Settings
           9.2.2 Hospitals/Critical Care Centers
    9.3 Home Care
    9.4 Research Laboratories
    9.5 Other End Users

10 Point-of-Care Diagnostics Market, By Region (Page No. - 116)
     10.1 Introduction
     10.2 North America
             10.2.1 US
             10.2.2 Canada
     10.3 Europe
             10.3.1 Germany
             10.3.2 France
             10.3.3 UK
             10.3.4 Rest of Europe (RoE)
     10.4 Asia Pacific
             10.4.1 Japan
             10.4.2 China
             10.4.3 India
             10.4.4 Rest of Asia Pacific
     10.5 Rest of the World (RoW)
             10.5.1 Latin America
             10.5.2 Middle East & Africa

11 Competitive Landscape (Page No. - 169)
     11.1 Overview
     11.2 Market Share Analysis, 2016
     11.3 Competitive Scenario and Trends
             11.3.1 Product Launches
             11.3.2 Agreements, Partnerships, and Collaborations
             11.3.3 Product Approvals
             11.3.4 Acquisitions

12 Company Profiles (Page No. - 173)
(Business Overview, Products Offered, Recent Developments, MnM View)*
     12.1 Abbott Laboratories
     12.2 Accubiotech
     12.3 Becton, Dickinson, and Company (BD)
     12.4 Chembio Diagnostics
     12.5 Danaher Corporation
     12.6 EKF Diagnostics
     12.7 Instrumentation Laboratory (A Werfen Company)
     12.8 Johnson & Johnson
     12.9 Nova Biomedical
     12.10 PTS Diagnostics (A Part of Sinocare Inc.)
     12.11 Quidel
     12.12 Roche Diagnostics (A Subsidiary of F. Hoffmann-La Roche Ltd.)
     12.13 Sekisui Diagnostics
     12.14 Siemens
     12.15 Trinity Biotech

*Business Overview, Products Offered, Recent Developments, MnM View Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. - 217)
     13.1 Discussion Guide
     13.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
     13.3 Introducing RT: Real-Time Market Intelligence
     13.4 Available Customizations
     13.5 Related Reports
     13.6 Author Details


List of Tables (129 Tables)

Table 1 Point-of-Care Diagnostics Market, By Product, 2015–2022 (USD Million)
Table 2 Point-of-Care Diagnostics Market for Glucose Monitoring Products, By Type, 2015–2022 (USD Million)
Table 3 Glucose Monitoring Meters Market, By Region, 2015–2022 (Units)
Table 4 Point-of-Care Diagnostics Market for Glucose Monitoring Products, By Region, 2015–2022 (USD Million)
Table 5 Point-of-Care Diagnostics Market for Cardiometabolic Testing Products, By Type, 2015–2022 (USD Million)
Table 6 Point-of-Care Diagnostics Market for Cardiometabolic Testing Products, By Region, 2015–2022 (USD Million)
Table 7 Cardiac Marker Testing Products Market, By Region, 2015–2022 (USD Million)
Table 8 Cardiac Marker Testing Products Market, By Region, 2015–2022 (Units)
Table 9 Blood Gas/Electrolytes Testing Products Market, By Region, 2015–2022 (USD Million)
Table 10 Blood Gas/Electrolytes Testing Analyzers Market, By Region, 2015–2022 (Units)
Table 11 HBA1C Testing Products Market, By Region, 2015–2022 (USD Million)
Table 12 Point-of-Care Diagnostics Market for Infectious Disease Testing Products, By Type, 2015–2022 (USD Million)
Table 13 Point-of-Care Diagnostics Market for Infectious Disease Testing Products, By Region, 2015–2022 (USD Million)
Table 14 Point-of-Care Diagnostics Market for Influenza Testing Products, By Region, 2015–2022 (USD Million)
Table 15 Influenza Testing Analyzers Market, By Region, 2015–2022 (Units)
Table 16 HIV Testing Products Market, By Region, 2015–2022 (USD Million)
Table 17 HIV Testing Analyzers Market, By Region, 2015–2022 (Units)
Table 18 Hepatitis C Testing Products Market, By Region, 2015–2022 (USD Million)
Table 19 Hepatitis C Testing Analyzers Market, By Region, 2015–2022 (Units)
Table 20 STD Testing Products Market, By Region, 2015–2022 (USD Million)
Table 21 Healthcare-Associated Infection Testing Products Market, By Region, 2015–2022 (USD Million)
Table 22 Respiratory Infection Testing Products Market, By Region, 2015–2022 (USD Million)
Table 23 Tropical Disease Testing Products Market, By Region, 2015–2022 (USD Million)
Table 24 Other Infectious Disease Testing Products Market, By Region, 2015–2022 (USD Million)
Table 25 Point-of-Care Diagnostics Market for Coagulation Testing Products, By Type, 2015–2022 (USD Million)
Table 26 Point-of-Care Diagnostics Market for Coagulation Testing Products, By Region, 2015–2022 (USD Million)
Table 27 Coagulation Testing Analyzers Market, By Region, 2015–2022 (Units)
Table 28 PT/INR Testing Products Market, By Region, 2015–2022 (USD Million)
Table 29 ACT/APTT Testing Products Market, By Region, 2015–2022 (USD Million)
Table 30 Point-of-Care Diagnostics Market for Pregnancy and Fertility Testing Products, By Type, 2015–2022 (USD Million)
Table 31 Point-of-Care Diagnostics Market for Pregnancy and Fertility Testing Products, By Region, 2015–2022 (USD Million)
Table 32 Pregnancy Testing Products Market, By Region, 2015–2022 (USD Million)
Table 33 Fertility Testing Products Market, By Region, 2015–2022 (USD Million)
Table 34 Point-of-Care Diagnostics Market for Tumor/Cancer Marker Testing Products, By Region, 2015–2022 (USD Million)
Table 35 Point-of-Care Diagnostics Market for Urinalysis Testing Products, By Region, 2015–2022 (USD Million)
Table 36 Urinalysis Testing Analyzers Market, By Region, 2015–2022 (Units)
Table 37 Point-of-Care Diagnostics Market for Cholesterol Testing Products, By Region, 2015–2022 (USD Million)
Table 38 Cholesterol Testing Analyzers Market, By Region, 2015–2022 (Units)
Table 39 Point-of-Care Diagnostics Market for Hematology Testing Products, By Region, 2015–2022 (USD Million)
Table 40 Hematology Testing Analyzers Market, By Region, 2015–2022 (Units)
Table 41 Point-of-Care Diagnostics Market for Drugs-of-Abuse Testing Products, By Region, 2015–2022 (USD Million)
Table 42 Point-of-Care Diagnostics Market for Fecal Occult Testing Products, By Region, 2015–2022 (USD Million)
Table 43 Point-of-Care Diagnostics Market for Other POC Products, By Region, 2015–2022 (USD Million)
Table 44 POC Diagnostics Market, By Platform, 2015–2022 (USD Million)
Table 45 Lateral Flow Assays Market, By Region, 2015–2022 (USD Million)
Table 46 Dipsticks Market, By Region, 2015–2022 (USD Million)
Table 47 Microfluidics Market, By Region, 2015–2022 (USD Million)
Table 48 Molecular Diagnostics Market, By Region, 2015–2022 (USD Million)
Table 49 Immunoassays Market, By Region, 2015–2022 (USD Million)
Table 50 Point-of-Care Diagnostics Market, By Prescription Mode, 2015–2022 (USD Million)
Table 51 Prescription-Based Testing Market, By Region, 2015–2022 (USD Million)
Table 52 OTC Testing Products Market, By Region, 2015–2022 (USD Million)
Table 53 Point-of-Care Diagnostics Market, By End User, 2015–2022 (USD Million)
Table 54 Point-of-Care Diagnostics Market for Professional Diagnostic Centers, By Type, 2015–2022 (USD Million)
Table 55 Point-of-Care Diagnostics Market for Professional Diagnostic Centers, By Region, 2015–2022 (USD Million)
Table 56 Point-of-Care Diagnostics Market for Clinical Laboratories, Outpatient Healthcare & Ambulatory Care Settings, By Region, 2015–2022 (USD Million)
Table 57 Point-of-Care Diagnostics Market for Hospitals/Critical Care Centers, By Region, 2015–2022 (USD Million)
Table 58 Point-of-Care Market for Home Care, By Region, 2015–2022 (USD Million)
Table 59 Point-of-Care Diagnostics Market for Research Laboratories, By Region, 2015–2022 (USD Million)
Table 60 Point-of-Care Diagnostics Market for Other End Users, By Region, 2015–2022 (USD Million)
Table 61 Point-of-Care Diagnostics Market, By Region, 2015–2022 (USD Million)
Table 62 North America: Point-of-Care Diagnostics Market, By Country, 2015–2022 (USD Million)
Table 63 North America: Point-of-Care Diagnostics Market, By Product, 2015–2022 (USD Million)
Table 64 North America: Point-of-Care Diagnostics Market, By Prescription Mode, 2015–2022 (USD Million)
Table 65 North America: Point-of-Care Diagnostics Market, By Platform, 2015–2022 (USD Million)
Table 66 North America: Point-of-Care Diagnostics Market, By End User, 2015–2022 (USD Million)
Table 67 US: Point-of-Care Diagnostics Market, By Product, 2015–2022 (USD Million)
Table 68 US: Point-of-Care Diagnostics Market, By Prescription Mode, 2015–2022 (USD Million)
Table 69 US: Point-of-Care Diagnostics Market, By Platform, 2015–2022 (USD Million)
Table 70 US: Point-of-Care Diagnostics Market, By End User, 2015–2022 (USD Million)
Table 71 Canada: Point-of-Care Diagnostics Market, By Product, 2015–2022 (USD Million)
Table 72 Canada: Point-of-Care Diagnostics Market, By Prescription Mode, 2015–2022 (USD Million)
Table 73 Canada: Point-of-Care Diagnostics Market, By Platform, 2015–2022 (USD Million)
Table 74 Canada: Point-of-Care Diagnostics Market, By End User, 2015–2022 (USD Million)
Table 75 Europe: Point-of-Care Diagnostics Market, By Country, 2015–2022 (USD Million)
Table 76 Europe: Point-of-Care Diagnostics Market, By Product, 2015–2022 (USD Million)
Table 77 Europe: Point-of-Care Diagnostics Market, By Prescription Mode, 2015–2022 (USD Million)
Table 78 Europe: Point-of-Care Diagnostics Market, By Platform, 2015–2022 (USD Million)
Table 79 Europe: Point-of-Care Diagnostics Market, By End User, 2015–2022 (USD Million)
Table 80 Germany: Point-of-Care Diagnostics Market, By Product, 2015–2022 (USD Million)
Table 81 Germany: Point-of-Care Diagnostics Market, By Prescription Mode, 2015–2022 (USD Million)
Table 82 Germany: Point-of-Care Diagnostics Market, By Platform, 2015-2022 (USD Million)
Table 83 Germany: Point-of-Care Diagnostics Market, By End User, 2015–2022 (USD Million)
Table 84 France: Point-of-Care Diagnostics Market, By Product, 2015–2022 (USD Million)
Table 85 France: Point-of-Care Diagnostics Market, By Prescription Mode, 2015–2022 (USD Million)
Table 86 France: Point-of-Care Diagnostics Market, By Platform, 2015–2022 (USD Million)
Table 87 France: Point-of-Care Diagnostics Market, By End User, 2015–2022 (USD Million)
Table 88 UK: Point-of-Care Diagnostics Market, By Product, 2015–2022 (USD Million)
Table 89 UK: Point-of-Care Diagnostics Market, By Prescription Mode, 2015–2022 (USD Million)
Table 90 UK: Point-of-Care Diagnostics Market, By Platform, 2015–2022 (USD Million)
Table 91 UK: Point-of-Care Diagnostics Market, By End User, 2015–2022 (USD Million)
Table 92 RoE: Point-of-Care Diagnostics Market, By Product, 2015–2022 (USD Million)
Table 93 RoE: Point-of-Care Diagnostics Market, By Prescription Mode, 2015–2022 (USD Million)
Table 94 RoE: Point-of-Care Diagnostics Market, By Platform, 2015–2022 (USD Million)
Table 95 RoE: Point-of-Care Diagnostics Market, By End User, 2015–2022 (USD Million)
Table 96 APAC: Point-of-Care Diagnostics Market, By Country, 2015–2022 (USD Million)
Table 97 APAC: Point-of-Care Diagnostics Market, By Product, 2015–2022 (USD Million)
Table 98 APAC: Point-of-Care Diagnostics Market, By Prescription Mode, 2015–2022 (USD Million)
Table 99 APAC: Point-of-Care Diagnostics Market, By Platform, 2015–2022 (USD Million)
Table 100 APAC: Point-of-Care Diagnostics Market, By End User, 2015–2022 (USD Million)
Table 101 Japan: Point-of-Care Diagnostics Market, By Product, 2015–2022 (USD Million)
Table 102 Japan: Point-of-Care Diagnostics Market, By Prescription Mode, 2015–2022 (USD Million)
Table 103 Japan: Point-of-Care Diagnostics Market, By Platform, 2015–2022 (USD Million)
Table 104 Japan: Point-of-Care Diagnostics Market, By End User, 2015–2022 (USD Million)
Table 105 China: Point-of-Care Diagnostics Market, By Product, 2015–2022 (USD Million)
Table 106 China: Point-of-Care Diagnostics Market, By Prescription Mode, 2015–2022 (USD Million)
Table 107 China: Point-of-Care Diagnostics Market, By Platform, 2015–2022 (USD Million)
Table 108 China: Point-of-Care Diagnostics Market, By End User, 2015–2022 (USD Million)
Table 109 India: Point-of-Care Diagnostics Market, By Product, 2015–2022 (USD Million)
Table 110 India: Point-of-Care Diagnostics Market, By Prescription Mode, 2015-2022 (USD Million)
Table 111 India: Point-of-Care Diagnostics Market, By Platform, 2015–2022 (USD Million)
Table 112 India: Point-of-Care Diagnostics Market, By End User, 2015–2022 (USD Million)
Table 113 RoAPAC: Point-of-Care Diagnostics Market, By Product, 2015–2022 (USD Million)
Table 114 RoAPAC: Point-of-Care Diagnostics Market, By Prescription Mode, 2015–2022 (USD Million)
Table 115 RoAPAC: Point-of-Care Diagnostics Market, By Platform, 2015–2022 (USD Million)
Table 116 RoAPAC: Point-of-Care Diagnostics Market, By End User, 2015–2022 (USD Million)
Table 117 RoW: Point-of-Care Diagnostics Market, By Country, 2015–2022 (USD Million)
Table 118 RoW: Point-of-Care Diagnostics Market, By Product, 2015–2022 (USD Million)
Table 119 RoW: Point-of-Care Diagnostics Market, By Prescription Mode, 2015–2022 (USD Million)
Table 120 RoW: Point-of-Care Diagnostics Market, By Platform, 2015–2022 (USD Million)
Table 121 RoW: Point-of-Care Diagnostics Market, By End User, 2015–2022 (USD Million)
Table 122 Latin America: Point-of-Care Diagnostics Market, By Product, 2015–2022 (USD Million)
Table 123 Latin America: Point-of-Care Diagnostics Market, By Prescription Mode, 2015–2022 (USD Million)
Table 124 Latin America: Point-of-Care Diagnostics Market, By Platform, 2015–2022 (USD Million)
Table 125 Latin America: Point-of-Care Diagnostics Market, By End User, 2015–2022 (USD Million)
Table 126 Middle East & Africa: Point-of-Care Diagnostics Market, By Product, 2015–2022 (USD Million)
Table 127 Middle East & Africa: Point-of-Care Diagnostics Market, By Prescription Mode, 2015–2022 (USD Million)
Table 128 Middle East & Africa: Point-of-Care Diagnostics Market, By Platform, 2015-2022 (USD Million)
Table 129 Middle East & Africa: Point-of-Care Diagnostics Market, By End User, 2015–2022 (USD Million)


List of Figures (36 Figures)

Figure 1 Research Methodology Steps
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Data Triangulation
Figure 4 Global Point-of-Care Diagnostics Market, By Product, 2017 vs 2022
Figure 5 Global Point-of-Care Diagnostics Market, By Prescription Mode, 2017 vs 2022
Figure 6 Global Point-of-Care Diagnostics Market, By Platform, 2017 vs 2022
Figure 7 Global Point-of-Care Diagnostics Market, By End User, 2017 vs 2022
Figure 8 Global Point-of-Care Diagnostics Market, By Region, 2017 (USD Million)
Figure 9 High Prevalence of Infectious Diseases is Driving the Adoption of POC Devices Across the Globe
Figure 10 Lateral Flow Assays Segment Will Continue to Dominate the Market in 2022
Figure 11 Professional Diagnostic Centers Segment to Dominate the Global POC Diagnostics End-User Market in 2017
Figure 12 Glucose Monitoring Segment to Dominate the POC Diagnostics Products Market During the Forecast Period
Figure 13 Prescription-Based Testing Products to Dominate the POC Diagnostics Market During the Forecast Period
Figure 14 North America to Register the Highest CAGR During the Forecast Period
Figure 15 POC Diagnostics Market: Drivers, Restraints, Opportunities, and Challenges
Figure 16 Estimated Number of Diabetic Patients, By Region, 2015 vs 2040
Figure 17 The Infectious Disease Testing Products Segment is Projected to Grow at the Highest CAGR During the Forecast Period
Figure 18 Molecular Diagnostics Segment to Witness Highest Growth Rate During the Forecast Period
Figure 19 OTC Testing Segment to Witness Higher Growth During the Forecast Period
Figure 20 Home Care to Witness Highest Growth During the Forecast Period
Figure 21 Point-of-Care Diagnostics Market: Growth Forecast, By Region (2017–2022)
Figure 22 North America: Point-of-Care Diagnostics Market Snapshot
Figure 23 Europe: Point-of-Care Diagnostics Market Snapshot
Figure 24 APAC: Point-of-Care Diagnostics Market Snapshot
Figure 25 Key Developments By Leading Market Players in the Market, 2015–2017
Figure 26 Point-of-Care Diagnostics Market Share, By Key Players, 2016
Figure 27 Abbott Laboratories: Company Snapshot
Figure 28 BD: Company Snapshot
Figure 29 Chembio Diagnostics: Company Snapshot
Figure 30 Danaher Corporation: Company Snapshot
Figure 31 EKF Diagnostics: Company Snapshot
Figure 32 Johnson & Johnson: Company Snapshot
Figure 33 Quidel: Company Snapshot
Figure 34 Roche Diagnostics: Company Snapshot
Figure 35 Siemens: Company Snapshot
Figure 36 Trinity Biotech: Company Snapshot


Request for detailed methodology, assumptions & how numbers were triangulated.

Please share your problem/objectives in greater details so that our analyst can verify if they can solve your problem(s).
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)
Report Code
MD 2702
Published ON
Feb, 2018
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Point-of-Care/Rapid Diagnostics Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved